海正藥業(600267.SH):擬對資產重組方案進行適當調整
格隆匯 11 月 25日丨海正藥業(600267.SH)公佈,公司第八屆董事會第二十次會議決議,逐項審議通過《關於公司調整本次交易方案的議案》。
鑑於資本市場環境變化,同意公司對此次發行股份、可轉換公司債券及支付現金購買HPPC Holding SARL (“交易對方”或“HPPC”)持有的瀚暉製藥有限公司(“瀚暉製藥”)49%股權並募集配套資金方案進行適當調整,終止員工持股計劃並取消募集配套資金中員工持股計劃認購可轉換公司債券安排,並相應調整向HPPC支付對價的方式。此次交易完成後,公司直接持有並通過全資子公司海正藥業(杭州)有限公司持有瀚暉製藥100%的股份。
此次交易中,公司擬向公司實際控制人台州市椒江區國有資本運營集團有限公司(“椒江國運”)非公開發行股票募集配套資金,募集配套資金總額不超過7億元,不超過此次交易中以發行股份和可轉債方式購買資產交易價格的100%。此次募集配套資金髮行股份數量不超過本次交易前公司總股本的30%,最終發行數量將以中國證券監督管理委員會核准的結果為準。
此次購買資產不以募集配套資金到位為前提。若配套資金募集成功,公司使用募集配套資金支付此次交易的現金對價。若募集配套資金未能及時到位或順利實施,公司將使用自有資金、銀行貸款或其他合法方式募集資金,以滿足本次交易現金對價的支付要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.